• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I ANTI-HCV REAGENT KIT; ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I ANTI-HCV REAGENT KIT; ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS Back to Search Results
Catalog Number 08P06-74
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/08/2020
Event Type  malfunction  
Manufacturer Narrative
There was no further patient information provided by the customer.This report is being filed on an international product, list number 8p06 that has a similar product distributed in the us, list number 8p05.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed false nonreactive alinity i anti-hcv results on one patient when using different lot number of reagents.The results provided were: anti-hcv results using lot number 14467be00 on alinity ai03718=1.19 s/co (>or=1.00 s/co=reactive)/repeated on alinity ai03119 =1.21 s/co and 1.26 s/co.Anti-hcv result using lot number 18312be00 on alinity ai03718=0.4 s/co, and 0.37 s/co (<1.00 s/co=nonreactive)/, repeated on alinity ai03119 =0.35 s/co and 0.36 s/co.There was no reported impact to patient management.
 
Manufacturer Narrative
A search of complaints for alinity i anti-hcv assay, lot 18312be01 identified no similar complaints and no trends for the customer's issue.An investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of the manufacturing documentation, review of field data, device history record and a review of product labeling.This review did not find any abnormal complaint activity and no trends were identified.Return testing was not completed as returns were not available.A retained reagent kit of lot number 18312be01 was tested in a sensitivity setup and results of this setup did not implicate that the performance of the lot was negatively impacted.Testing includes additional replicates of the positive control and two commercially available seroconversion panels (zeptometrix hcv seroconversion panels hcv 9047 and hcv 9045).All specifications were met indicating the lot is performing acceptably.Device history record review did not identify any non-conformances or deviations with the likely cause lot and complaint issue.A review of the manufacturing documentation did not identify any issues associated with the customers observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the alinity i anti-hcv assay, lot number 18312be01.Updated information section d4: updated lot number to 18312be01 from 18312be00 and catalog number to 08p06-74 to 08p06-22.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I ANTI-HCV REAGENT KIT
Type of Device
ASSAY, ENZYME LINKED IMMUNOSORBENT, HEPATITIS C VIRUS
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10720644
MDR Text Key214800817
Report Number3002809144-2020-01036
Device Sequence Number1
Product Code MZO
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/18/2021
Device Catalogue Number08P06-74
Device Lot Number18312BE01
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 10/08/2020
Initial Date FDA Received10/22/2020
Supplement Dates Manufacturer Received12/17/2020
Supplement Dates FDA Received12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI03119; ALNTY I PROCESSING MODU, 03R65-01, AI03119
-
-